1. Netarsudil ophthalmic solution 0.02%: First global approval;Hoy S. M.;Drugs.,2018
2. Discovery and preclinical development of netarsudil, a novel ocular hypotensive agent for the treatment of glaucoma;Lin C. W.;J Ocul. Pharmacol. Ther.,2018
3. An emerging treatment option for glaucoma: Rho kinase inhibitors;Wang S. K.;Clin. Ophthalmol.,2014
4. Rho kinase (ROCK) inhibitors and their therapeutic potential;Feng Y.;J. Med. Chem.,2016
5. Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research;Rao P. V.;Exp. Eye. Res.,2016